4
Changes in Ownership
REGENERON PHARMACEUTICALS, INC. Filed Acc 0001968202-24-000138
EVP Research and Development gave up 466 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
STAHL NEIL · EVP Research and Development
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-12-09 | Shares withheld for taxes : show line 1 in the form | −466 | $787.00 | $366,742 | 49,133 | D |
Loading xslF345X05/edgardoc.xml…